Advocacy
Awareness
Education
Research
PKDF Chief Science Officer Dr. David Baron co-authors new paper with FDA and top nephrologists
Only a few new drugs for chronic kidney disease (CKD) have been approved in the last several decades because drug companies have shied away from the renal “space.” The need for novel therapies for CKD is compelling, especially because they might mitigate the need...
PKDF Director of Government Affairs recaps the 2018 ASN Kidney Week
This year’s American Society of Nephrology (ASN) Kidney Week took place in San Diego, CA, from Oct. 25 to 28. We always look forward to Kidney Week to hear about new developments and initiatives being made in the world of nephrology. Alexis Denny, our Director of...
Join the PKD Foundation for #GivingTuesday
#GivingTuesday is right around the corner, and this year, we're asking: what can you give? Can you give a donation? Our goal for #GivingTuedsay is to raise $18,000 — the amount needed to fund ten weeks of PKD research. When you select the PKD Foundation as your...
How motherhood inspired PKD patient to get involved with tolvaptan clinical trials
This Mother’s Day, we’re celebrating moms and major milestones. We reached out to Jullie Hoggan, who took part in the clinical trials that led to the approval of tolvaptan, to learn more about what having this treatment means to her and her family: The day I became...
PKD researcher weighs in on how patient participation brought about first treatment
The announcement of our first FDA-approved treatment for ADPKD is not only a major success for PKD patients, but also for nephrologists who have spent decades caring for their health. We reached out recently to Vicente Torres, M.D., Ph.D., of the Mayo Clinic...
PKD Foundation Chief Scientific Officer’s take on FDA-approved treatment as a PKD patient
Our very own Dr. David Baron shares his personal background with PKD, his journey joining the Foundation and his thoughts on the exciting news about the new treatment for ADPKD: Little did I know when I was studying the effects of vasopressin and its...
-
Only a few new drugs for chronic kidney disease (CKD) have been approved in the last several decades because drugRead More -
This year’s American Society of Nephrology (ASN) Kidney Week took place in San Diego, CA, from Oct. 25 to 28.Read More
-
#GivingTuesday is right around the corner, and this year, we’re asking: what can you give? Can you give a donation?Read More -
This Mother’s Day, we’re celebrating moms and major milestones. We reached out to Jullie Hoggan, who took part in theRead More -
The announcement of our first FDA-approved treatment for ADPKD is not only a major success for PKD patients, but alsoRead More -
Dr. David Baron, PKD Foundation Chief Scientific Officer Our very own Dr. David Baron shares his personal background with PKD,Read More
